Stock screenerAll disclosures → EDGAR →
PLX
Broke outConviction 49LongHealthcareScan · Thu, Jun 25, 2026Ascending triangletriangle
PLX$2.21-1.34%
ResistanceSupportVol 14Vol MA14 603.44K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Trade plan
LongReward : Risk0.34Entry
Entry
2.21
Risk
Stop
1.86
-16.0% to stop
Reward
Target 1
2.33
+5.5% to target
Stretch
Target 2
2.45
+11.0% to T2
Risk : reward balance
Risk to stopReward to target
Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.
Price2.21
Change-1.34%
Gap+0.22%
Rel volume0.98×
Avg volume622.01K
Avg $ vol1.3M
SMA 202.07
SMA 502.08
SMA 2002.19
Price vs 50+6.16%
Price vs 200+1.03%
MA stackmixed
50/200 cross—
Supertrendup · 1.94
RSI (14)60
MACD hist0.03
MACD cross—
Stoch %K / %D78 / 78
ADX (14)20
+DI / −DI27 / 12
RSI divergence—
MACD divergence—
ATR %+4.15%
ADR %3.81%
52w high3.15
52w low1.38
From 52w high-29.84%
Above 52w low+60.14%
New 52w highNo
SqueezeOff
Bollinger width16.95%
%B0.90
Donchian pos77.94%
Donchian high2.29
Donchian low1.95
AVWAP (52w high)2.32
vs AVWAP high-4.59%
AVWAP (52w low)2.19
vs AVWAP low+0.85%
OBV trendFlat
Chaikin MF (20)-0.15
Today vs 20d0.98×
Avg vol (14d)603.43K
Avg vol (20d)622.01K
Avg $ vol (20d)1.3M
Market cap178.06M
RS 3m (vs SPY)-4.04%
RS 6m (vs SPY)+21.74%
RS line new highNo
Trend template5/8
Technical rank70.9
1 week+9.41%
1 month+3.27%
3 months+2.31%
6 months+23.46%
1 year+44.44%
YTD+27.01%
P/E-26.96
P/B2.65
P/S3.38
P/FCF-13.06
EPS-0.0800
Div yield—
ROE-9.82%
ROA-6.45%
Debt/Eq0.01
Current3.15
EV/EBITDA—
Gross margin7.60%
Net margin-12.52%
Rev growth-1.23%
EPS growth-325.24%
Price target12.00
Target upside442.99%
Analyst ratingBuy
Institutional21.59%
Ent. value137.97M
Revenue33.75M
Net income18.32M
Gross profit-1.25M
Free cash flow-13.63M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNYSE
Shares out80.57M
Employees226
ListedTue, Jan 2, 1996
Free float71.57M
Float %89.0%
Short interest3.94M
Days to cover4.9d
Short volume51.7%
Squeeze score43 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.22 vs −$0.01
Last surprise+2300.0% beat
Setup gradeC
Conviction49 / 100
Pattern quality78%
Tech rank70.9 / 100
Group rank50 / 100
Status laneBroke out
Setup directionLong
Pattern familyTriangle
Resistance2.11
Support1.88
Days since event4d
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in PLX
No recent disclosed trades by Congress in PLX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PLX
No recent insider (Form 4) filings in PLX. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in PLX · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.